Challenges in the sustainable public purchase of biosimilar medicines
encarnacion cruz
CEO of BioSim
On Tuesday, November 30, 2021, these informative breakfasts were held in which the report 'Public purchase of biosimilars as an efficiency tool for the National Health System' was presented.
PRESENTATIONS
The Public Sector Contracts Law and the acquisition of biosimilar medicines: basic aspects and practical recommendations
Esmeralda Martos
Head of the Legal Department of Teresa de Hospitalidad